Literature DB >> 15573134

AKAP signalling complexes: focal points in space and time.

Wei Wong1, John D Scott.   

Abstract

Multiprotein signalling networks create focal points of enzyme activity that disseminate the intracellular action of many hormones and neurotransmitters. Accordingly, the spatio-temporal activation of protein kinases and phosphatases is an important factor in controlling where and when phosphorylation events occur. Anchoring proteins provide a molecular framework that orients these enzymes towards selected substrates. A-kinase anchoring proteins (AKAPs) are signal-organizing molecules that compartmentalize various enzymes that are regulated by second messengers.

Mesh:

Substances:

Year:  2004        PMID: 15573134     DOI: 10.1038/nrm1527

Source DB:  PubMed          Journal:  Nat Rev Mol Cell Biol        ISSN: 1471-0072            Impact factor:   94.444


  457 in total

1.  Phosphodiesterases catalyze hydrolysis of cAMP-bound to regulatory subunit of protein kinase A and mediate signal termination.

Authors:  Balakrishnan Shenbaga Moorthy; Yunfeng Gao; Ganesh S Anand
Journal:  Mol Cell Proteomics       Date:  2010-10-05       Impact factor: 5.911

Review 2.  A-kinase anchoring proteins that regulate cardiac remodeling.

Authors:  Graeme K Carnegie; Brian T Burmeister
Journal:  J Cardiovasc Pharmacol       Date:  2011-11       Impact factor: 3.105

3.  Stably tethered multifunctional structures of defined composition made by the dock and lock method for use in cancer targeting.

Authors:  Edmund A Rossi; David M Goldenberg; Thomas M Cardillo; William J McBride; Robert M Sharkey; Chien-Hsing Chang
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

4.  An entirely specific type I A-kinase anchoring protein that can sequester two molecules of protein kinase A at mitochondria.

Authors:  Christopher K Means; Birgitte Lygren; Lorene K Langeberg; Ankur Jain; Rose E Dixon; Amanda L Vega; Matthew G Gold; Susanna Petrosyan; Susan S Taylor; Anne N Murphy; Taekjip Ha; Luis F Santana; Kjetil Tasken; John D Scott
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

Review 5.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 6.  A-kinase anchoring proteins as potential drug targets.

Authors:  Jessica Tröger; Marie C Moutty; Philipp Skroblin; Enno Klussmann
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

7.  Cotranslational cis-phosphorylation of the COOH-terminal tail is a key priming step in the maturation of cAMP-dependent protein kinase.

Authors:  Malik M Keshwani; Christian Klammt; Sventja von Daake; Yuliang Ma; Alexandr P Kornev; Senyon Choe; Paul A Insel; Susan S Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

8.  Optic atrophy 1 is an A-kinase anchoring protein on lipid droplets that mediates adrenergic control of lipolysis.

Authors:  Guillaume Pidoux; Oliwia Witczak; Elisabeth Jarnæss; Linda Myrvold; Henning Urlaub; Anne Jorunn Stokka; Thomas Küntziger; Kjetil Taskén
Journal:  EMBO J       Date:  2011-10-07       Impact factor: 11.598

9.  Distinct PKA regulatory subunits mediate PGE2 inhibition of TGFβ-1-stimulated collagen I translation and myofibroblast differentiation.

Authors:  Scott H Wettlaufer; L Raghu Penke; Katsuhide Okunishi; Marc Peters-Golden
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-07-20       Impact factor: 5.464

10.  The nuclear membrane organization of leukotriene synthesis.

Authors:  Asim K Mandal; Phillip B Jones; Angela M Bair; Peter Christmas; Douglas Miller; Ting-ting D Yamin; Douglas Wisniewski; John Menke; Jilly F Evans; Bradley T Hyman; Brian Bacskai; Mei Chen; David M Lee; Boris Nikolic; Roy J Soberman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.